section name header

Introduction ⬇

Iodine 131 body scanning is a nuclear study performed to assist in diagnosing metastatic thyroid cancer anywhere in the body or in detecting extrathyroidal tissue or residual thyroid tissue after a total thyroidectomy. The radionuclide 131I as MIBG I 131 is administered orally, followed by scanning to reveal concentrations in the neck, lungs, or bones, indicating metastatic activity.

Reference Values ⬆ ⬇

Interfering Factors ⬆ ⬇

Indications ⬆ ⬇

[Show Section Outline]

Indicationsnav

Contraindicationsnav


[Section Outline]

Care Before Procedure ⬆ ⬇

Nursing Care Before the Procedure

Client teaching and physical preparation are the same as for any nuclear scan study (see section under "Brain Scanning").

Procedure ⬆ ⬇

The client is given an oral dose of the radiopharmaceutical in a capsule and returned to or requested to return to the department 24 to 72 hours later. The client is then placed on the examining table in a supine position and requested to remain still while full body scanning is performed. Thyroid-stimulating hormone (TSH) can be administered IV before the radiopharmaceutical to stimulate any residual tissue to take up the radionuclide, if this is the reason for the study. A higher level of TSH also increases uptake by metastatic tumors.

Care After Procedure ⬆

Nursing Care After the Procedure

Care and assessment after the procedure are the same as for any nuclear scan study (see section under "Brain Scanning").